While oral GLP1s introduce greater upstream complexity and higher costs of goods, these realities are not always fully reflected in how oral therapies are perceived in the market
Healthcare providers typically recommend continuing Ozempic to maintain weight loss, similar to how blood pressure medications are used long-term to sustain health benefits
Drug information Related support groups Ozempic (121 questions, 240 members) Semaglutide (47 questions, 58 members) Diabetes, Type 2 (534 questions, 1,445 members) Facial Wrinkles (18 questions, 36 members) Facial Lipoatrophy (2 questions, 4 members)
Evidence status Phase 2 trial
Remarkably, 83% of participants experienced weight loss greater than 15%, a threshold associated with significant health benefits
Injectionsite nodules mainly exenatide ER